[Prospect of the development of new bactericidal drugs against Helicobacter pylori for eradication therapy].
Kamiya
Shigeru
S
Department of Infectious Diseases, Kyorin University School of Medicine.
Taguchi
Haruhiko
H
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001557:Benzenesulfonates / Q000494:pharmacology; D015780:Carbapenems / Q000494:pharmacology; D002594:Cetylpyridinium / Q000494:pharmacology; D015195:Drug Design; D024881:Drug Resistance, Bacterial; D004610:Ellagic Acid / Q000494:pharmacology; D005395:Fish Oils; D005504:Food Analysis; D019695:Glycyrrhizic Acid / Q000494:pharmacology; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D009582:Nitrofurantoin / Q000494:pharmacology; D012294:Rifamycins / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001557:Benzenesulfonates; D015780:Carbapenems; D005395:Fish Oils; D012294:Rifamycins; D013844:Thiazoles; D004610:Ellagic Acid; D019695:Glycyrrhizic Acid; D009582:Nitrofurantoin; D002594:Cetylpyridinium; C075156:ebrotidine